导师风采
黄晓婕
浏览量:517   转发量:7

个人信息

Personal Information

  • 教授
  • 导师类别:硕士,博士生导师
  • 性别: 女
  • 学历:硕士研究生
  • 学位:博士

联系方式

Contact Information

  • 所属院系:附属北京佑安医院
  • 所属专业: 内科学(传染病)
  • 邮箱 : huangxiaojie78@126.com
  • 工作电话 : -

个人简介

Personal Profile

黄晓婕,首都医科大学博士,1978年6月生人,主任医师,教授,博导,留英留美(牛津大学及洛克菲勒大学)访问学者。学术任职:中国研究型医院感染病学专委会常委兼秘书长;中国性病艾滋病协会青年专委会常务委员,艾滋病多学科专委会委员,中华医学会北京感染病学分会委员,北京市感染质量控制中心专家委员,中华中医药学会防治艾滋病分会第五届委员会常务委员。北京市科学技术委员会科技专家库评审专家,首都卫生发展专项基金评审专家,教育部评审专家。2022年入选重大传染病疫情的全球卫生治理方向高层次公共卫生技术人才(学科带头人),2020年入选北京市百千万人才工程(中青年领军人才),2019年入选北京市优秀人才青年拔尖人才项目。

于首都医科大学附属北京佑安医院工作20年,主要研究方向为各种感染性疾病临床及基础研究,艾滋病抗病毒治疗及机会性感染诊治。2014年由国家卫健委委派,作为援非专家赴几内亚抗击埃博拉,获得“中华之光”援非集体奖;2022年由国家卫健委委派,作为传染病领域专家对口支援大凉山美姑县人民医院开展艾滋病-结核-丙肝-梅毒四病同防同治援助工作。

科研方面,以负责人承担国家十三五传染病重大专项子课题、国家自然科学基金、首发基金及国际合作等多项国家科研项目,课题经费超1500万元; 发表中英文章160余篇,第一/通讯作者在JAMA Network Open, Journal of AIDS,Journal of Infectious Diseases, Pharmacological Research, Frontiers in immunology上发表SCI 收录论文60篇,累计影响因子380分。2012年及2013年荣获“首都十大疾病重大科技成果奖”两项;获得2019年度北京市“科学技术奖科技进步奖”二等奖1项。


  • 研究方向Research Directions
艾滋病临床及基础研究,艾滋病抗病毒治疗联合免疫治疗研究,艾滋病微生物及其他组学研究
2. 机电结构优化与控制 研究内容:在对机电结构进行分析和优化的基础上,运用控制理论进行结构参数的调整,使结构性能满足设计要求。1. 仿生结构材料拓扑优化设计, 仿生机械设计 研究内容:以仿生结构为研究对象,运用连续体结构拓扑优化设计理论和方法,对多相仿生结构(机构)材料进行2. 机电结构优化与控制 研究内容:在对机电结构进行分析和优化的基础上,运用控制理论进行结构参数的调整,使结构性能满足设计要求。1. 仿生结构材料拓扑优化设计, 仿生机械设计 研究内容:以仿生结构为研究对象,运用连续体结构拓扑优化设计理论和方法,对多相仿生结构(机构)材料进行整体布局设计。 整体布局设计。
团队展示


带领科研团队并以负责人承担国家十三五传染病重大专项子课题、国家自然科学基金、首发基金及国际合作等多项国家科研项目,课题经费1000余万元; 发表中英文章160余篇,第一/通讯作者在The Lancet Regional Health - Western Pacifific,JAMA Network Open, Journal of AIDS, Journal of Infectious Diseases, Pharmacological Research, Frontiers in immunology上发表SCI 收录论文50篇,累积影响因子260分。科研团队既往在市科委重大专项和传染病重大专项的支持下,已建立了全球单个中心最大的急性期 HIV 感染者队列,且团队目前维持艾滋病抗病毒治疗长期随访队列10000余例,在艾滋病基础研究和临床诊治方面积累了丰富经验,建有艾滋病大数据样本资源库,涵盖流行病学调查信息与疾病信息。早在2006年北京市科委就已拉开了“艾滋病防治策略及综合防治研究”的序幕,由申请单位牵头,联合国家CDC、北京市CDC、北京各大医院及科研机构等十余家艾滋病研究优势单位,整合了北京地区科研及临床资源,共同完成了大型前瞻性队列研究——Beijing PRIMO Cohort(“北京原发HIV感染队列”),建立了全球最大的单中心覆盖8000人的HIV阴性MSM队列及500人的原发感染者前瞻性队列。艾滋病实验室为北京市重点实验室,实验室约占300平方米,拥有16色流式分选细胞仪、CantooII流式细胞仪、酶标仪、激光共聚焦显微镜、超速冰冻离心机、低温离心机、凝胶扫描仪、分子杂交炉、普通PCR仪、实时测序仪、ABI7900实时定量PCR仪、EasyQ病毒载量检测仪、bDNA病毒载量检测仪、倒置荧光显微镜、生物安全柜、细胞培养箱、纯水仪等实验仪器设备,可以进行免疫学、细胞生物学、分子生物学等的相关研究,这些设备基础和技术基础为本团队的科学研究提供了必要的保障。作为团队带头人组织开展多学科合作,同五官科,心血管内科,超声科均有密切合作课题及相关论文产出。



项目情况

以负责人承担国家十三五传染病重大专项子课题、国家自然科学基金、首发基金及国际合作等多项国家科研项目,课题经费1000余万元。在研课题如下:

1.血管内皮炎症因子对艾滋病合并心血管相关疾病预测作用的巢式病例对照研究,首都卫生发展科研专项自主创新项目,负责人,经费32万元,2022年01月-2024年12月。

2.基于HIV分子传播网络技术的艾滋病重点人群精准干预及效果评估研究分课题,首都卫生发展科研专项重点攻关项目,负责人,经费90万元,2022年01月-2024年12月。

3.多替拉韦和利福喷丁为基础的治疗方案对初治HIV/AIDS合并肺结核的疗效评估研究,北京协和医院中央高水平医院临床科研专项(FW-KYQT2022090501451),负责人,合作经费10万元,2022年09月-2024年12月。

4.首都医科大学附属北京佑安医院人才库[41-45周岁],CX3CL1/CX3CR1通路对CD8+T细胞的调控在HIV感染疾病进展中的作用,经费5万元

,2022年09月-2024年12月。

5.2022吉利德科学推进HIV预防的创新研究(NOVA)计划(2022-9131),MSM人群HIV感染风险筛查系统的开发和评估,全自动AI聊天机器人提供在线实时检测指导和CBO转诊到专科医院服务,负责人,经费28万美元,2023年01月-2024年06月

6.高层次公共卫生技术人才建设项目(学科带头人-02-12),重大传染病疫情的全球卫生治理方向,经费90万元,2023年01月-2025年12月。


近5年科研项目

一、人才项目

1.高层次公共卫生技术人才建设项目(学科带头人) 2023

2.北京市百千万人才工程项目(领军人才)2021

3.北京市优秀人才(青年拔尖个人项目) 2019

二、科研课题

1.国家自然科学青年基金  2018-2020

2.十三五传染病重大专项  2017-2020

3.首都卫生发展科研专项项目 2022-2024

4.NOVA创新计划 2023-2024

5.首都卫生发展科研专项项目 2022-2024

6.北京协和医院中央高水平医院临床科研专项 2022-2024


研究成果

重要学术论文:

1.      XinshengWu#, Guohui Wu#, Ping Ma#, Rugang Wang#, Linghua Li#, Yuanyi Chen, Junjie Xu,Yuwei Li, Quanmin Li, Yuecheng Yang, Lijing Wang, Xiaoli Xin, Ying Qiao,Gengfeng Fu*, Xiaojie Huang*, Bin Su*, Tong Zhang*, Hui Wang*, HuachunZou*. Associations of modern initial antiretroviral therapy regimens withall-cause mortality in people living with HIV in resource-limited settings: aretrospective multicenter cohort study in China. Nature Communications. 2023Sep 2;14(1):5334. doi: 10.1038/s41467-023-41051-w. (IF:16.6) [Q1]

2.      XinshengWu#, Guohui Wu#, Ping Ma#, Rugang Wang#, Linghua Li#, Yinghui Sun, Junjie Xu,Yuwei Li, Tong Zhang, Quanmin Li, Yuecheng Yang, Lijing Wang, Xiaoli Xin, YingQiao, Bingxue Fang, Zhen Lu, Xinyi Zhou, Yuanyi Chen, Qi Liu, Gengfeng Fu,Hongxia Wei*, Xiaojie Huang*, Bin Su*,Hui Wang*, Huachun Zou*. Immediate and long-term outcomes after treat-all amongpeople living with HIV in China: an interrupted time series analysis. Infectiousdiseases of poverty. 2023 Aug 14;12(1):73. doi:10.1186/s40249-023-01119-7. (IF:8.1) [Q1]

3.      WenjingWang #, Shengnan Zhao #, Yaxin Wu #, Wenshan Duan, Sibo Li, Zhen Li, CaipingGuo, Wen Wang, Tong Zhang, Hao Wu, Xiaojie Huang*. Safety and Efficacyof Long-Acting Injectable Agents for HIV-1: Systematic Review andMeta-Analysis. JMIR Public Health Surveill. 2023 Jul 27;9:e46767.doi: 10.2196/46767. (IF:8.5) [Q1]

4.      MengluLiu#, Hanying Qiu#, Wenyan Zhang, Tingting Mei, Shan Tang, Yuxue Gao, YanqiuZhu, Xiaojie Huang*, Haibin Yu*. Evaluation of blood-based PRO-C3testing as a diagnostic marker for staging liver fibrosis: A systematic reviewand meta-analysis. J Gastroenterol Hepatol. 2023Jul;38(7):1018-1027. doi: 10.1111/jgh.16240. (IF:4.369) [Q2]

5.      ZhenLi#*, Ping Yan#, Rui Wang, Xiaofan Lu, Yang Zhang, Bin Su, Xin Zhang, Lin Yuan,Zhiying Liu, Wei Jiang, Tong Zhang, Hao Wu*, Xiaojie Huang*. PersistentT cell proliferation and MDSCs expansion precede incomplete CD4+ Tcell recovery in people with acute HIV-1 infection with early ART. Heliyon.2023 Apr 18;9(5):e15590. doi: 10.1016/j.heliyon.2023.e15590. (IF:3.776) [Q2]

6.      YangZhao#, Juan Du#, Zhen Li, Yaxin Wu, Wenshan Duan, Wenjing Wang, Tong Zhang,Junjie Xu*, Hao Wu*, Xiaojie Huang*. It Is Time to Improve theAcceptance of COVID-19 Vaccines Among People with Chronic Diseases: ASystematic Review and Meta-analysis. J Med Virol. 2023Feb;95(2):e28509. doi: 10.1002/jmv.28509. (IF: 20.693) [Q1]

7.      ChiZhou#, Yaxin Wu#, Yang Zhang#, Yingying Wang, Hao Wu, Tong Zhang*, Guanzhi Chen*,Xiaojie Huang*. Factors Associated with Post-treatment Control of ViralLoad in HIV-Infected Patients: A Systematic Review and Meta-analysis. IntJ Infect Dis. 2023 Apr;129:216-227. doi: 10.1016/j.ijid.2023.01.025.(IF: 12.074) [Q1]

8.      JiaojiaoLiu#, Benedictor Alexander Nguchu#, Dan Liu, Yu Qi, Xire Aili, Shuai Han, YuxunGao, Xiaoxiao Wang, Hongwei Qiao, Chao Cai, Xiaojie Huang*, Hongjun Li*.Longitudinal white matter alterations in SIVmac239-infected rhesus monkeyswith and without regular cART treatment. Front Immunol. 2023 Jan12;13:1067795. doi: 10.3389/fimmu.2022.1067795. (IF: 8.786) [Q2]

9.      XiangfeiXiu, Yuanyuan Qin, Yugang Bao, Yaokai Chen, Hao Wu, Xiaojie Huang*, LuWang*. The Practice and Potential Role of HIV Self-testing in China:Systematic Review and Meta-analysis. JMIR Public HealthSurveill. 2022 Dec 2;8(12):e41125. doi: 10.2196/41125.(IF: 14.557) [Q1]

10.   SisiChen#, Feng Ren#, Ling Xu; Yao Gao, Xiangying Zhang, Yaling Cao,Zihao Fan, YuanTian, Xiaojie Huang*, Mei Liu*. Underestimated Prevalence of HIV,Hepatitis B Virus (HBV), and Hepatitis D Virus (HDV) Triple Infection Globally:Systematic Review and Meta-analysis. JMIR Public Health Surveill.2022 Nov 29;8(11):e37016. doi: 10.2196/37016. (IF:14.557) [Q1]

11.XinshengWu#, GuohuiWu#, YanminMa#, XiaojieHuang#,YuechengYang#, YanshanCai#, GanfengLuo, PingMag, YingQiao, YuanyiChen, Yi-FanLin,YanxiaoGao, YueweiZhan, WeiSong, YingyingWang, RugangWang, XuejuanYang, LijunSun,HongxiaWei, QuanminLi, Xia, liXin, LijingWang, XichengWang, Ronghu, Xie, LijuanYang,XiaojunMeng, JinZhao*, LinghuaLi*, TongZhang*, JunjieXu*, GengfengFu*,HuachunZoua*. The impact of COVID-19 non-pharmaceuticalinterventions on HIV care continuum in China: an interrupted timeseries analysis. Lancet Regional Health-Western Pacific. 2022 Aug10;29:100569. doi: 10.1016/j.lanwpc.2022.100569.(IF:8.559)[Q1]

12.   YaxinWu#, Yuening Zhang#, Yingying Wanga, Jiaqi Weia, b, WenjingWanga, Wenshan Duana, Yakun Tiana, Meixin Rena, Zhen Lia, b, Wen Wanga, TongZhanga, Hao Wua, Xiaojie Huang*. Bedaquiline and Linezolid improveanti-TB treatment outcome in drug-resistant TB patients with HIV: A systematicreview and meta-analysis. Pharmacol Res. 2022 Aug;182:106336.doi: 10.1016/j.phrs.2022.106336. (IF:10.334) [Q1]

13.   Kui-FangDu#, Xiao-Jie Huang#, Chao Chen, Wen-Jun Kong, Lian-Yong Xie, Hong-WeiDong* and Wen-Bin Wei *. Macular Changes Observed on Optical CoherenceTomography Angiography in Patients Infected with Human Immunodeficiency Virus WithoutInfectious Retinopathy. Front Med (Lausanne). 2022 Apr 7;9:820370. doi: 10.3389/fmed.2022.820370. (IF:5.058) [Q2]

14.   YanYu, Xinyu Wang, Yaxin Wu, Wenjia Weng, Ming Zhang, Juan Li, Xiaojie Huang*,Yanqing Gao*. The benefits of psychosocial interventions for mental health inmen who have sex with men living with HIV: a systematic review andmeta-analysis. BMC Psychiatry. 2022 Jun 29;22(1):440. doi:10.1186/s12888-022-04072-1. (IF:4.144) [Q2]

15.   HongyiWang#, Zixin Wang#, Xiaojie Huang#, Yaokai Chen, Hui Wang, Sitong Cui,Jing Zhang, Zhenxing Chu, Qinghai Hu, Haibo Ding, Hanzhu Qian, Huachun Zou,Weiming Tang, Yangyang Gao, Xia Jin, Zhaozhen Liu, Lukun Zhang, Jin Zhao,Xiaoqing He, Yongjun Jiang, Wenqing Geng, Junjie Xu*, Hong Shang*; for theChina Real-World Oral Intake of PrEP (CROPrEP) Study Team. Association of HIVpreexposure prophylaxis use with HIV incidence among men who have sex with menin China: a nonrandomized controlled trial. JAMA Network Open. 2022 Feb 1;5(2):e2148782. doi: 10.1001/jamanetworkopen.2021.48782.(IF:13.353) [Q1]

16.   KeZhang#, Yang Zhang#, Jing Zhou, Lulu Xu, Chi Zhou, Guanzhi Chen*, XiaojieHuang*. Comparison of the Efficacy and Safety of a Doravirine-Based,Three-Drug Regimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian NetworkMeta-Analysis. FrontPharmacol. 2022 Apr 20;13: 676831. doi:10.3389/fphar.2022.676831. (IF:5.988) [Q1]

17.   XiaoyanBi#, Fan Liu#, Xiangjun Zhang, Hongyi Wang, Zehao Ye, Ke Yun, Xiaojie Huang#,Haibo Ding, Wenqing Geng, and Junjie Xu*. Vitamin D and calciumsupplementation reverses Tenofovir-caused bone mineral density loss inpopulations attending ART or PrEP: a systematic review and meta-analysis. Front Nutr. 2022Mar 31;9: 749948. doi: 10.3389/fnut.2022.749948. (IF:6.59) [Q1]

18.   ZhuangTao#, Chong Ma, Jipeng Dong, Huijun Guo, Xin Li, Xinghua Tan, Yuqi Yang,Jianping Ma, Shuiqing Liu, Jian Wang∗, Xiaojie Huang∗.The Immunomodulatory Effects of Artesunate on Immunological Non-responders inLong-term ART-treated People Living with HIV in Selected Provinces in China: ANon-randomized Concurrent Control Trial. Pharmacological Research-ModernChinese Medicine, 2022 Jun; 3: 100067. doi.org/10.1016/j.prmcm.2022.100067.(IF: 3.829) [Q1]

19.   XiaojieHuang #, Ying Yan #, Bin Su #, Dong Xiao#, Maohe Yu, XiaJin, Junyi Duan, Xiangjun Zhang, Shimin Zheng, Yuan Fang, Tong Zhang, WeimingTang *, Lunan Wang *, Zixin Wang * and Junjie Xu*. Comparing ImmuneResponses to Inactivated Vaccines against SARS-CoV-2 between People Living withHIV and HIV-Negative Individuals: A Cross-Sectional Study in China.Viruses. 2022 Jan 28;14(2):277. doi: 10.3390/v14020277. (IF:5.818) [Q2]

20.   XinyuWang#, Ming Zhang#, Yu Chen. Yirong Liu, Yan Yu, Xiaojie Huang*. YanqingGao*. Risk for Hepatitis B Virus Reactivation in Patients with PsoriasisTreated with Biological Agents: A Systematic Review and Meta-Analysis. DermatolTher (Heidelb). 2022 Mar;12(3):655-670. doi: 10.1007/s13555-022-00682-5.(IF:3.858) [Q2]

21.   YakunTian#, Wei Hua#, Yaxin Wu#, Tong Zhang, Wen Wang, Hao, Wu, Caiping Guo*, XiaojieHuang*. Immune response to hepatitis B virus vaccine among people livingwith HIV: a meta-analysis. Front Immunol, 2021 Dec 22;12: 745541.doi: 10.3389/fimmu.2021.745541 (IF:8.786) [Q1]

22.   XiaojingLian#, Lili Zhang#, Yang Zhao#, Yuhua Li, Xuemin Jing, Xin Liu, Jianing Han,Jianhong Ma, Yongyong Zhang, Huimin Guo*, Xiaojie Huang*. Utilizationof a mobile multifunctional workstation for coronavirus nasopharyngeal/oropharyngealspecimen collection. Front Public Health, 2021 Jan24;9:794359. doi: 10.3389/fpubh.2021.794359. eCollection 2021. (IF:6.461)[Q1]

23.   YingGuo#, Xiaojie Huang#, Xintong Sun, Yixi Yu, Yan Wang, Baojin Zhang, JieCao, Shuo Wen, Yuchen Li, Xin Wang, Siyu Cai, Wei Xia, Feili Wei, Junyi Duan,Haozhi Dong, Shan Guo, Fengqiu Zhang*, Dongxiang Zheng* and Zheng Sun*. Theunderrated salivary virome of men who have sex with men infected with HIV. FrontImmunol, 2021 Dec 2;12: 759253. doi:10.3389/fimmu.2021.759253 (IF:8.786) [Q1]

24.   ZhuangTao, Xiao-Jie Huang*, Ying Liu, Ru Wang, Ji-Peng Dong, Bi-Yan Liang, WenZou, Guo-Jian Gao, Zhuo Wang, Ke Zhang, Hao Wu, Tong Zhang, Jian Wang*. Efficacyof integrated Traditional Chinese Medicine and anti-retroviral therapy onimmunological nonresponse in patients with human immunodeficiencyvirus/acquired immunodeficiency syndrome: a Meta-analysis of randomizedcontrolled trial. J Tradit Chin Med. 2021Oct;41(5):669-676. doi: 10.19852/j.cnki.jtcm.2021.05.002. (IF: 2.547) [Q3]

25.  HuanXia#, Xiao-Jie Huang#, Yue Hu, Li-Ying Gao, Yue Wu, Hao Wu, Zhong-FangYan, Ping Ma*. Switching from efavirenz toelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces centralnervous system symptoms in people living with human immunodeficiency virus. Chin Med J (Engl). 2021 Oct 13. doi:10.1097/CM9.0000000000001824.(IF:6.133) [Q1]

26.  Chunxiang Guo#, Yaxin Wu#, Yang Zhang,Xinchao Liu, Aixin LI, Meixia Gao, Tong Zhang, Hao Wu, Guanzhi Chen*, XiaojieHuang *. Transmitted drug resistance in ART-naivepersons with acute/ early/ primary HIV infection: a systematic review andmeta-analysis. Frontiersin Pharmacology. 2021 Nov24;12: 718763. doi: 10.3389/fphar.2021.718763 (IF:5.988) [Q1]

27.   Xiaojie Huang#,Maohe Yu#, Gengfeng Fu#, Guanghua Lan#, Linghua Li#, Jianzhou# Yang, YingQiao#, Jin Zhao#, Han-Zhu Qian, Xiangjun Zhang, Xinchao Liu, Xia Jin,GuohongChen, Hui Jiang, Weiming Tang*, Zixin Wang*, Junjie Xu*.Willingness to receive COVID-19 vaccination among people living with HIV andAIDS in China: A nationwide cross-sectional online survey. JMIR PublicHealth Surveill. 2021 Oct 21;7(10): e31125. doi: 10.2196/31125. (IF:14.557)[Q1]

28.   NiWang, Muyu Wang, Xin Xin, Tong Zhang, Hao Wu, Xiaojie Huang* andHonglei Liu*. Exploring the Relationship between Anxiety, Depression, and SleepDisturbance among HIV Patients in China from a Network Perspective. FrontPsychiatry. 2021 Oct 22;12: 764246.doi: 10.3389/fpsyt.2021.764246. (IF:5.435)[Q2]

29.   YingyingWang#, Xiaojie Huang#, Yaxin Wu, Aixin Li, Yakun Tian, Meixin Ren, ZhenLi,Tong Zhang, Hao Wu and Wen Wang*. Increased Risk of Vitamin D DefificiencyAmong HIV-Infected Individuals: A Systematic Review and Meta-Analysis. FrontNutr. 2021 Aug 18;8: 722032. doi: 10.3389/fnut.2021.722032. (IF:6.59)[Q1]

30.  Ke Zhang, Yang Zhang, Xincao Liu, AinxinLi, Meixia Gao, Jianhua Hou, Chunxiang Guo, Tong Zhang, Hao Wu, XiaojieHuang*, Guanzhi Chen*. Three-drug regimens containing integrase inhibitorshow good efficacy and safety in treatment-naive patients with HIV-1: aBayesian analysis. Front Pharmacol.2021 Jul 21;12: 603068. doi:10.3389/fphar.2021.603068. (IF:5.988) [Q1]

31.   JingZhang#, Xiao-jie Huang#, Wei-ming Tang#, Zhen-xing Chu#, Qing-hai Hu,Jing Liu, Haibo Ding, Xiao-xu Han, Zi-ning Zhang, Yong-jun Jiang, Wen-qingGeng, Wei Xia , Jun-jie Xu* and Hong Shang*. Rapid Clinical Progression and ItsCorrelates Men in China with Acute HIV Who Have Sex With Men: Findings From a5-Year Multicenter Prospective Cohort Study. Front Immunol. 2021Jul 22;12: 712802. doi: 10.3389/fimmu.2021.712802. (IF:8.786) [Q1]

32.  Yang Zhao, Xiaoli Xin, Huiwen Deng, JunjieXu, Wenjia Weng, Ming Zhang, Juan Li, Yanqing Gao, Xiaojie Huang*, Cuie Liu*. Improving theacceptability of human papillomavirus vaccines among men who have sex with menaccording to the correlated factors: a systematic review and meta-analysis. Front Pharmacol. 2021 Mar 24;12: 600273. doi:10.3389/fphar.2021.600273. (IF: 5.81) [Q1]

33.  Guo, Y#, Xia, W, Wei, F, Feng, W, Duan, J,Sun, X, Yu, Y, Wang, Y, Zhang, B, Cao, J, Li, W, Dong, H, Guo, S, Zhang, F*, Huang,X* & Sun, Z*.Salivary microbial diversity at different stages of human immunodeficiencyvirus infection. Microb Pathog. 2021 Jun;155: 104913. doi:10.1016/j.micpath.2021.104913. (IF:3.847) [Q3]

34.  HuX#, Huang X#, Hou J, Ding L, Su C,Meng F*. Diagnostic accuracy of spleen stiffness to evaluate portalhypertension and esophageal varices in chronic liver disease: a systematicreview and meta-analysis. Eur Radiol. 2021 Apr;31(4):2392-2404. doi:10.1007/s00330-020-07223-8. (IF=4.101) [Q1]

35.  Xia,H. #, Gao, L. #, Gong, X., Zaongo, S. D., Zhang, T., Wu,H., Ma, P. * & Huang, X*. TheChallenge of Potential Drug–Drug Interactions Among People Living With HIV onAntiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China. Frontiers in Pharmacology. 2020, May 27;11:800. doi:10.3389/fphar.2020.00800. eCollection 2020. (IF:4.225) [Q1]

36.  Li,Y. #, Huang, X. #, Chen, H., Qin, Y., Hou, J., Li, A.,Wu,H. , Yang, X.& Chen, Y*. The prevalence of cryptococcal antigen (CrAg)and benefits of pre-emptive antifungal treatment among HIV-infected personswith CD4+ T-cell counts< 200 cells/μL: evidence based on ameta-analysis. BMC InfectiousDiseases. 2020 Jun12;20(1):410. doi: 10.1186/s12879-020-05126-z. (IF:2.688) [Q3]

37.  Qin,Y. #, Huang, X. #,Chen, H., Liu, X.Li, Y., Hou, J., Li, A., Yan, X, Chen, Y*. Burden ofTalaromyces marneffei infection in people living with HIV/AIDS in Asia duringART era:a systematic review and meta-analysis. BMC Infectious Diseases. 2020 Jul 29;20(1):551. doi: 10.1186/s12879-020-05260-8. (IF:2.688)[Q3]

38.  YuanGao #, Qi Li #, Hongbo Shi #, Yingmei Feng,Tong Zhang, Yu Chen, Lianchun Liang, Dexi Chen, Hao Wu, Ronghua Jin, XiaojieHuang *. Preliminary Exploration of the Cause of Liver DisordersDuring Early Stages in COVID-19 Patients. Frontiersin Medicine. 2020 Aug 7;7:501.doi: 10.3389/fmed.2020.00501. (IF:3.9) [Q2]

39.  XuJJ#, Huang XJ#, Liu XC, Wang LM,Chen YK, Wang H, Zhang FJ, Wu H, Li TS, Han MJ, Zhao F, Ding HB, Duan JY, ShengGS, Shang H*. Consensusstatement on human immunodeficiency virus pre-exposure prophylaxis in China. Chin Med J (Engl). 2020Dec 5;133(23):2840-2846. doi: 10.1097/CM9.0000000000001181. (IF=1.555)[Q1]

40.  HuangX#, Xu L#, Sun L, Gao G, Cai W, Liu Y, DingH, Wei H, Ma P, Wang M, Liu S, Chen Y, Chen X, Zhao Q, Yu J, Song Y, Chen H, WuH, Qin S*, Li L*. Six-year Immunologic Recovery and Virological Suppression ofLPV/r-based Second-line Antiretroviral among HIV Patients: A Multi-center Real-worldCohort Study in China. Frontiers inPharmacology. 2019 Dec11;10:1455. doi: 10.3389/fphar.2019.01455. (IF:3.845) [Q1]

41.  HuangY#, Huang X#, Chen H, Wu H*, Chen Y*. Efficacy andsafety of raltegravir based dual therapy in AIDS patients: a meta-analysis fromrandomized controlled trials. Frontiersin Pharmacology. 2019 Oct17;10:1225. doi: 10.3389/fphar.2019.01225. (IF:3.845) [Q1]

42.  ZhangY, Hou J, Shi P, Chang S, Wu A, Song A, Wu H, Huang X*, Shi J*.Problem-based learning could tackle the issue of insufficient education andadherence in people living with HIV/AIDS[J]. Frontiers in pharmacology. 2019 Aug 21;10:901. doi: 10.3389/fphar.2019.00901. (IF:3.845) [Q1]

43.   Zhiyuan Yang#, Xiaojie Huang#, Xinchao Liu,Jianhua Hou, Wenfang Wu,Aixin Song, Kathrine Meyers, Tong Zhang, Hui Chen*, HaoWu*. Psychometric Properties and Factor Structure of the Chinese Version of theHospital Anxiety and Depression Scale in People Living With HIV. Frontiers in Psychiatry. 2019 May 16;10:346. doi: 10.3389/fpsyt.2019.00346. (IF:2.875) [Q2]

44.   Hu X#, Huang X#, Chen H, Zhang T, Hou J, Song A, Ding L, Liu W,Wu H*, Meng F*. Diagnostic effect of shear wave elastography imaging fordifferentiation of malignant liver lesions: a meta-analysis. BMC gastroenterology. 2019 Apr 25;19(1):60. doi:10.1186/s12876-019-0976-2. (IF:2.252) [Q4]

45.   XiaojieHuang #,Xinchao Liu #, Jieqing Chen #, Yugang Bao, Hou Jianhua, LuXiaofan, Xia Wei, Xia Huan, Song Aixin, Liu Zhiying, Su Bin, Chen Hui*, ChenYaokai*, Wu Hao*. Evaluation of Blood-Based Antibody Rapid Testing for HIVEarly Therapy: A Meta-Analysis of the Evidence. Frontiers in Immunology. 2018 Jun26;9:1458. doi: 10.3389/fimmu.2018.01458.(IF:5.511)[Q1]

46.   Yinqiu Huang#, Xiaojie Huang#, Yadong Luo,Yihong Zhou, Xingbao Tao, Hui Chen, Aixin Song, Yaokai Chen *, Hao Wu *.Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and AlternativeSecond-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidenceto Support WHO Recommendations. Frontiersin pharmacology. 2018 Aug14;9:890. doi: 10.3389/fphar.2018.00890. (IF:3.831) [Q1]

47.   XiaojieHuang#, JianhuaHou#, Aixin Song, Xinchao Liu, Xiaodong Yang, Junjie Xu, Jing Zhang,Qinghai Hu, Hui Chen, Yaokai Chen, Kathrine Meyers *, Hao Wu *. Efficacy andsafety of oral TDF-based pre-exposure prophylaxis for men who have sex withmen: A systematic review and meta-analysis. Frontiers in pharmacology. 2018 Sep 4;9:799. doi: 10.3389/fphar.2018.00799.(IF:3.831)[Q1]

48.   XiaojieHuang #,Kathrine Meyers #, Xinchao Liu #, Xia Li, Tong Zhang, WeiXia, Jiahua Hou, Aixin Song, Haolan He, Chongxi Li, Shenghua He, Weiping Cai,Huolin Zhong, Chengyu Huang, Shuiqing Liu, Hui Wang, Xuemei Ling, Ping Ma,Rongxia Ye, Gang Xiao, Taisheng Li, Ding Ding, Kristine Yaffe, Hui Chen *,Yaokai Chen *, Hao Wu *. The Double Burdens of Mental Health Among AIDSPatients with Fully Successful Immune Restoration: A Cross-Sectional Study ofAnxiety and Depression in China. Frontiersin Psychiatry. 2018 Aug 24;9:384. doi:10.3389/fpsyt.2018.00384. (IF: 2.875) [Q2]

49.   Aixin Song #, Xinchao Liu #,Xiaojie Huang #, KathrineMeyers, Djin Ye Oh, Jianhua Hou, Wei Xia, Bin Su, Ni Wang, Xiaofan Lu, Huan Xia,Xiaodong Yang, Hui Chen *, Hao Wu *. From CD4-Based Initiation to Treating AllHIV-Infected Adults Immediately: An Evidence-Based Meta-analysis. Frontiers in Immunology.2018Feb 13;9:212. doi: 10.3389/fimmu.2018.00212. (IF: 6.429) [Q1]

50.   XiaojieHuang#, Huiqin Li#, Kathrine Meyers #, Wei Xia, ZhihaoMeng, Chongxi Li, Jinsong Bai, Shenghua He, Weiping Cai, Chengyu Huang,Shuiqing Liu, Hui Wang Xuemei Ling, Ping Ma, Daling Tan, Fuxiang Wang, LianguoRuan, Hongxin Zhao, HongxiaWei, Yanfen Liu, Jianhua Yu, Hongzhou Lu, Min Wang,Tong Zhang, Hui Chen*, Hao Wu*. Burdenof sleep disturbances and associated risk factors: A crosssectional surveyamong HIV infected persons on antiretroviral therapy across China. ScientificReports. 2017 Jun 16;7(1):3657.doi: 10.1038/s41598-017-03968-3. (IF: 4.259) [Q2]

51.   Xiaojie Huang#,Xinchao Liu #,Kathrine Meyers #,Lihong Liu, Bin Su, Pengfei Wang, Zhen Li, Lan Li, Tong Zhang, Ning Li, HuiChen*, Haiying Li*, Hao Wu*. Cytokinecascade and networks among MSM HIV seroconverters: implications for earlyimmunotherapy. Scientific Reports. 2016 Nov 10;6:36234. doi: 10.1038/srep36234. (IF:5.228) [Q2]

52.   Xiaofan Lu #, Bin Su #,Huan Xia, Xin Zhang, Zhiying Liu, Yunxia Ji, Zixuan Yang, Lili Dai, Luzia M. Mayr, Christiane Moog, Hao Wu, Xiaojie Huang* andTong Zhang*. Low Double-Negative CD3+CD4−CD8− T Cells Are Associated with IncompleteRestoration of CD4+ T Cells and Higher Immune Activation in HIV-1 ImmunologicalNon-Responders. Front Immunol. 2016 Dec 9;7:579. doi:10.3389/fimmu.2016.00579. (IF:5.695) [Q1]

53.   Xiaojie Huang #, Yuanlong Xu#, Qiuying Yang, Jieqing Chen, Tong Zhang, ZaiCunLi, Caiping Guo, Hui Chen*, Hao Wu*, Ning Li*. Efficacy and biological safetyof lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infectedpatients: a meta-analysis of randomized controlled trials. Scientific Reports. 2015Feb 23;5:8528. doi: 10.1038/srep08528. (IF:5.578) [Q2]

54.   Zhongwei Jia #, Xiaojie Huang #, Hao Wu* #, Tong Zhang #, Ning Li, Peipei Ding,Yixuan Sun, Zhiying Liu, FeiliWei, Hongwei Zhang, Yanmei Jiao, Yunxia Ji, Yonghong Zhang, Caiping Guo, WeiLi, Danlei Mou, Wei Xia, Zhen Li, Dexi Chen, Huiping Yan, Xinyue Chen, JinkouZhao, Kathrine Meyers, Ted Cohen, Kenneth Mayer, Joshua A Salomon, Zuhong Lu *, Christopher Dye*. HIV burden in men whohave sex with men: a prospective cohort study 2007–2012. Scientific Reports. 2015 Jul 2;5:11205. doi: 10.1038/srep11205. (IF: 5.578) [Q2]

55.   Xiaojie Huang, Sara Lodi , Zoe Fox,Wei Li, Andrew Phillips, KholoudPorter, Irja Lutsar, Anthony Kelleher, Ning Li,  Xiaoning Xu , Hao Wu* and Anne M Johnson. Beijing PRIMO cohort studyCASCADE Collaboration in EuroCoord. Rate ofCD4 decline and HIV-RNA change following HIV Seroconversion in men who have sexwith men: a comparison between the Beijing PRIMO and CASCADE cohorts. JAIDS. 2013 Apr 1;62(4):441-6. doi: 10.1097/QAI.0b013e31827f5c9a. (IF:4.653) [Q3]

56.   Chen J#, Li W#, HuangX#, Guo C#, Zou R, Yang Q, Zhang H, Zhang T, Chen H*,Wu H*. Evaluating Total Lymphocyte Count as a Surrogate Marker for CD4 CellCount in the Management of HIV-Infected Patients in Resource-Limited Settings:A Study from China. PLoS ONE.2013 Jul 18;8(7):e69704. doi: 10.1371/journal.pone.0069704. (IF:3.73) [Q2]

57.   Xiaojie Huang, Hui Chen, Wei Li,Haiying Li, Xia Jin, Alan S. Perelson, Zoe Fox, Tong Zhang, Xiaoning Xu, Hao Wu*. Precise determination of time toreach viral load set point after acute HIV-1 infection. JAIDS. 2012 Dec1;61(4):448-54. doi: 10.1097/QAI.0b013e31827146e0. (IF:4.653)[Q3]

58.   Chao Wang#, YouXin Wang#, XiaoJie Huang#, Xia Li , YouXin Wang , Tong Zhang , ManShu Song *, LiJuan Wu , Juan Du , XiaoQin Lu , ShuangShao , FeiFei Zhao , Michele A. Ball, Hao Wu*, Wei Wang*. Prevalenceand Factors Associated with  ADDINNE.Ref.{8D305615-A092-4CF3-8EA9-4462906BCA6E}Hepatitis B Immunization and Infection among Men Who Have Sexwith Men in Beijing, China. Plos One. 2012;7(10):e48219. doi: 10.1371/journal.pone.0048219.(IF:4.092) [Q2]

59.   Wei Li#,Xiaojie Huang#, Hongfei Tong, Yuxuan Wang,Tong Zhang, Wen Wang, LiliDai ,Tongzeng Li, Shengzhang Lin* ,Hao Wu*. Comparison of the regulation of β-catenin signaling by type I,type II and type III interferons in hepatocellular carcinoma cells. Plos One. 2012;7(10):e47040. doi:10.1371/journal.pone.0047040. (IF: 4.092) [Q2]

60.   Wei Li#,Xiaojie Huang#, Zhuoming Liu, Yuxuan Wang, HongweiZhang, Hongfei Tong, Hao Wu*, ShengzhangLin*. Type III interferoninduces apoptosis in human lung cancer cells. ONCOLOGY REPORTS. 2012Sep;28(3):1117-25. doi: 10.3892/or.2012.1901. (IF:1.835) [Q3]

61.   Xiao-jie Huang, Hai-ying Li, De-xi Chen, Xi-cheng Wang, Zai-cun Li, Ya-song Wu,Tong Zhang, Yan-qing Gao*, HaoWu*. Clinical Analysis of Skin Lesions in 796 Chinese HIV-positivePatients. Acta DermVenereol. 2011 Sep;91(5):552-6.doi: 10.2340/00015555-1107. (IF:2.94) [Q2]

62.   Haiying Li#,Xiaojie Huang# ,Caiping Guo, Wen Wang, Zaicun Li, Tong Zhang, Qiaoli Peng, Xinyue Chen, HaoWu*. Heightened T-cellproliferation without an elevation of CD4+ T cell spontaneous apoptosis in AIDSpatients. Clinical Immunology. 2008 Dec;129(3):499-508. doi:10.1016/j.clim.2008.08.004. (IF: 3.93) [Q1]

 

重要奖项:

1.HIV/HCV共感染及HIV单独感染者临床特点及发病机制研究与应用 北京市科学技术进步奖 二等奖 202008

2.我国男男性接触(MSM)人群HlV-1新发感染及疾病进展模式研究 首都十大疾病科技攻关 创新型科技成果 201311

3.艾滋病队列干预及致病机制研究 首都十大疾病重大科技成果 创新型科技成果 201303


学生信息
学术型硕士
学生信息
当前位置:教师主页 > 学生信息
入学日期
所学专业
学号
学位
招生信息
当前位置:教师主页 > 招生信息
招生学院
招生专业
研究方向
招生人数
推免人数
考试方式
招生类别
招生年份

首都医科大学研究生院招生办公室

360eol提供技术支持

Copyright © 2011 -All Rights Reserved 苏ICP备08015343号-4

文件上传中...

分享
回到
首页
回到
顶部